Cowen And Company, LLC Immunocore Holdings PLC Transaction History

Cowen And Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$60.14 - $75.36 $25 Million - $31.3 Million	-415,395 Reduced 77.43%	121,092 $7.87 Million
Q4 2023 Feb 12, 2024	BUY	$42.85 - $69.5 $23 Million - $37.3 Million	536,487 New	536,487 $36.7 Million
Q2 2023 Aug 07, 2023	BUY	$48.54 - $61.64 $2.66 Million - $3.38 Million	54,862 Added 13.54%	460,036 $27.6 Million
Q4 2022 Feb 09, 2023	SELL	$45.51 - $65.08 $27.6 Million - $39.5 Million	-606,496 Reduced 59.95%	405,174 $23.1 Million
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $37.8 Million - $58.1 Million	1,011,670 New	1,011,670 $47.5 Million

141

41.4M

197K

451K

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.24B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.